Imunon, Inc. (IMNN)
Nasdaq: IMNN · Pharmaceutical Preparations · Lawrenceville, NJ · filing with the SEC since 1996
Who owns Imunon, Inc.
As filed with the SECHolders of 5% or more
1
Armistice Capital, LLC holds 9.99% of Common stock, par value $0.01 per share, as its SCHEDULE 13G/A filed Aug 14, 2026 says.
Directors and officers
12
report now, of 22 people on the record since 2007. Their holdings as a group are not read here.
Institutions as a whole
n/a
The record does not read the share held by managers that file Form 13F, so none is printed and no split of the rest is estimated. What it holds is the 1 named at left.
Holders of 5% or moreshare of the class, as filed
Armistice Capital, LLC
SCHEDULE 13G/A · filed Aug 14, 2026 · Common stock, par value $0.01 per share · 9.99% in May 15, 2026
Mitchell P. Kopin
SCHEDULE 13G/A · filed Aug 12, 2025 · Common stock, par value $0.01 per share · reported falling below 5%, from 5.5% in May 30, 2025
Ayrton Capital LLC
SCHEDULE 13G/A · filed Aug 13, 2025 · Common stock, par value $0.01 per share · reported falling below 5%, from 7.9% in Feb 13, 2025
What IMNN reports owning in othersstakes of 5% or more, and other ties
1 subsidiary in 1 country, from the list filed with the 10-K filed Mar 31, 2026.
Insider tradesForm 4
6sales
0purchases
0sales on a scheduled plan
1people selling
$0sold, in dollars
$0bought, in dollars
Open-market trades on Form 4 from Nov 10, 2025 to Nov 10, 2026. A scheduled plan is a selling program set in advance under SEC rule 10b5-1. The trades are listed as filed and do not feed the grade.
By calendar yearSoldBought
2026 runs to Nov 10, 2026. Dollars as filed, summed by the transaction date.
People who traded in the window1 of 22 on the roster
| Person | Role as filed | Sales | Sold | On a plan | Buys | Bought |
|---|---|---|---|---|---|---|
| Eylward Susan | General Counsel and Corp Sec | 6 | $0 | 0 | 0 | $0 |